ME00567A - Ciclesonide contained pharmaceutical composition for application to mucosa - Google Patents

Ciclesonide contained pharmaceutical composition for application to mucosa

Info

Publication number
ME00567A
ME00567A MEP-856/08A MEP85608A ME00567A ME 00567 A ME00567 A ME 00567A ME P85608 A MEP85608 A ME P85608A ME 00567 A ME00567 A ME 00567A
Authority
ME
Montenegro
Prior art keywords
mucosa
application
pharmaceutical composition
ciclesonide
contained pharmaceutical
Prior art date
Application number
MEP-856/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00567(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00567B publication Critical patent/ME00567B/me
Publication of ME00567A publication Critical patent/ME00567A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MEP-856/08A 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa ME00567A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
YUP-280/02A RS50310B (sr) 1999-10-20 2000-10-20 Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (2)

Publication Number Publication Date
ME00567B ME00567B (me) 2011-12-20
ME00567A true ME00567A (en) 2011-12-20

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-856/08A ME00567A (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Country Status (36)

Country Link
US (1) US6767901B1 (xx)
EP (1) EP1225902B1 (xx)
JP (1) JP4264211B2 (xx)
KR (1) KR100722209B1 (xx)
CN (2) CN101869570B (xx)
AR (1) AR026072A1 (xx)
AT (1) ATE285779T1 (xx)
AU (1) AU781895B2 (xx)
BG (1) BG65818B1 (xx)
BR (1) BRPI0014878B8 (xx)
CA (1) CA2388322C (xx)
CO (1) CO5261494A1 (xx)
CZ (1) CZ297779B6 (xx)
DE (1) DE60017175T2 (xx)
DK (1) DK1225902T3 (xx)
EA (1) EA006015B1 (xx)
ES (1) ES2234681T3 (xx)
HK (2) HK1050858A1 (xx)
HR (1) HRP20020346B1 (xx)
HU (1) HU228893B1 (xx)
IL (2) IL148691A0 (xx)
ME (1) ME00567A (xx)
MX (1) MXPA02003974A (xx)
MY (1) MY136987A (xx)
NO (1) NO327444B1 (xx)
NZ (1) NZ518298A (xx)
PE (1) PE20010712A1 (xx)
PL (1) PL199702B1 (xx)
PT (1) PT1225902E (xx)
RS (1) RS50310B (xx)
SI (1) SI1225902T1 (xx)
SK (1) SK286196B6 (xx)
TR (1) TR200200841T2 (xx)
TW (1) TWI225788B (xx)
WO (1) WO2001028562A1 (xx)
ZA (1) ZA200203077B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CA2491724C (en) * 2002-07-02 2013-04-02 Altana Pharma Ag Ciclesonide-containing sterile aqueous suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
BR0312849A (pt) * 2002-07-26 2005-04-19 Fmc Corp Produção de celulose microcristalina
EP1545548B1 (en) * 2002-08-30 2010-06-30 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP4755495B2 (ja) * 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
JP2008512428A (ja) * 2004-09-10 2008-04-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
CA2717984C (en) * 2008-03-14 2013-11-26 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) * 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
AU7953100A (en) 2001-04-30
US6767901B1 (en) 2004-07-27
CN101869570A (zh) 2010-10-27
ZA200203077B (en) 2003-02-26
HRP20020346B1 (en) 2011-06-30
EP1225902B1 (en) 2004-12-29
AR026072A1 (es) 2002-12-26
IL148691A (en) 2006-12-10
HK1050858A1 (zh) 2003-07-11
RS50310B (sr) 2009-09-08
SK286196B6 (sk) 2008-05-06
DE60017175D1 (de) 2005-02-03
ES2234681T3 (es) 2005-07-01
BRPI0014878B1 (pt) 2015-08-11
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
SK6922002A3 (en) 2002-09-10
ME00567B (me) 2011-12-20
CZ20021238A3 (cs) 2002-07-17
PT1225902E (pt) 2005-05-31
HUP0203339A3 (en) 2004-07-28
CN1379674B (zh) 2014-10-29
CA2388322A1 (en) 2001-04-26
EP1225902A1 (en) 2002-07-31
WO2001028562A1 (en) 2001-04-26
CN1379674A (zh) 2002-11-13
IL148691A0 (en) 2002-09-12
HK1149719A1 (en) 2011-10-14
MY136987A (en) 2008-12-31
CO5261494A1 (es) 2003-03-31
KR100722209B1 (ko) 2007-05-29
JP4264211B2 (ja) 2009-05-13
TWI225788B (en) 2005-01-01
EA006015B1 (ru) 2005-08-25
EA200200375A1 (ru) 2002-10-31
YU28002A (sh) 2004-11-25
BRPI0014878B8 (pt) 2021-05-25
CA2388322C (en) 2007-09-18
NO327444B1 (no) 2009-06-29
NO20021898L (no) 2002-04-22
BR0014878A (pt) 2002-06-11
HUP0203339A2 (hu) 2003-02-28
TR200200841T2 (tr) 2002-07-22
DK1225902T3 (da) 2005-05-02
DE60017175T2 (de) 2005-12-29
ATE285779T1 (de) 2005-01-15
AU781895B2 (en) 2005-06-23
PL199702B1 (pl) 2008-10-31
CN101869570B (zh) 2012-10-10
HU228893B1 (hu) 2013-06-28
CZ297779B6 (cs) 2007-03-28
BG106512A (bg) 2002-12-29
JP2003512329A (ja) 2003-04-02
HRP20020346A2 (en) 2004-02-29
BG65818B1 (bg) 2010-01-29
MXPA02003974A (es) 2003-09-25
NO20021898D0 (no) 2002-04-22
PL356191A1 (en) 2004-06-14
PE20010712A1 (es) 2001-07-12
SI1225902T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
ME00567A (en) Ciclesonide contained pharmaceutical composition for application to mucosa
NZ501950A (en) Medicinal compositions for application to mucosa
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
RS49566B (sr) Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer
BR0112417A (pt) Composições farmacêuticas contendo composto dds
ES2281569T3 (es) Gotas para los ojos.
JP2002212042A (ja) 植物抽出物粉末の製造方法及びこの方法によって製造された植物抽出物粉末を含有する口腔用組成物
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
JP6050943B2 (ja) 保存安定性に優れたステイン形成阻害用液体口腔用組成物
CA2463384A1 (en) Hydrating nasal gel and applicator
JP4824343B2 (ja) 消炎鎮痛外用剤
GB0018322D0 (en) Pharmaceutical compositions
RU2220738C1 (ru) Средство для лечения ринита
JP2002068974A (ja) 抗真菌医薬組成物
JP2893807B2 (ja) アズレン誘導体含有液剤
MY124416A (en) Pharmaceutical composition for application to mucosa
JPH07107940A (ja) 経口美容剤
JP2006062968A (ja) むくみ改善剤
JP5663292B2 (ja) 口腔内用水性液製剤及び容器入り口腔内用水性液製剤
JPS63277606A (ja) 皮膚および毛髪用組成物
JPH04120017A (ja) 粘膜投与用液剤
JP2017043542A (ja) クラスター構造を有する粘膜細胞用清浄保湿剤
AR019245A1 (es) Composicion farmaceutica para ser aplicada a las mucosas